AU2004245198B2 - Indole derivatives with apoptosis-inducing effect - Google Patents

Indole derivatives with apoptosis-inducing effect Download PDF

Info

Publication number
AU2004245198B2
AU2004245198B2 AU2004245198A AU2004245198A AU2004245198B2 AU 2004245198 B2 AU2004245198 B2 AU 2004245198B2 AU 2004245198 A AU2004245198 A AU 2004245198A AU 2004245198 A AU2004245198 A AU 2004245198A AU 2004245198 B2 AU2004245198 B2 AU 2004245198B2
Authority
AU
Australia
Prior art keywords
substituted
unsubstituted
alkyl
indol
chlorobenzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2004245198A
Other languages
English (en)
Other versions
AU2004245198A1 (en
Inventor
Silke Bassner
Peter Emig
Matthias Gerlach
Eckhard Gunther
Peter Schmidt
Tilmann Schuster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aeterna Zentaris GmbH
Original Assignee
Zentaris AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP03012868A external-priority patent/EP1484329A1/de
Priority claimed from EP04011598A external-priority patent/EP1595878A1/de
Application filed by Zentaris AG filed Critical Zentaris AG
Publication of AU2004245198A1 publication Critical patent/AU2004245198A1/en
Application granted granted Critical
Publication of AU2004245198B2 publication Critical patent/AU2004245198B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2004245198A 2003-06-05 2004-05-25 Indole derivatives with apoptosis-inducing effect Ceased AU2004245198B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US47627703P 2003-06-05 2003-06-05
US60/476,277 2003-06-05
EP03012868.0 2003-06-06
EP03012868A EP1484329A1 (de) 2003-06-06 2003-06-06 Indolderivate mit Apoptose induzierender Wirkung
EP04011598A EP1595878A1 (de) 2004-05-15 2004-05-15 Indolderivate mit Apoptose induzierender Wirkung
EP04011598.2 2004-05-15
PCT/EP2004/005593 WO2004108702A1 (de) 2003-06-05 2004-05-25 Indolderivate mit apoptose induzierender wirkung

Publications (2)

Publication Number Publication Date
AU2004245198A1 AU2004245198A1 (en) 2004-12-16
AU2004245198B2 true AU2004245198B2 (en) 2009-04-23

Family

ID=43661564

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004245198A Ceased AU2004245198B2 (en) 2003-06-05 2004-05-25 Indole derivatives with apoptosis-inducing effect

Country Status (12)

Country Link
EP (1) EP1641777A1 (de)
JP (1) JP4878285B2 (de)
KR (1) KR101132599B1 (de)
CN (1) CN1816543B (de)
AU (1) AU2004245198B2 (de)
BR (1) BRPI0410998A (de)
CA (1) CA2526663C (de)
MX (1) MXPA05013121A (de)
NZ (1) NZ543853A (de)
RS (1) RS20050901A (de)
RU (1) RU2327696C2 (de)
WO (1) WO2004108702A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8217042B2 (en) 2005-11-11 2012-07-10 Zentaris Gmbh Pyridopyrazines and their use as modulators of kinases
EP1790342A1 (de) 2005-11-11 2007-05-30 Zentaris GmbH Pyridopyrazin-Derivate und deren Verwendung als Modulatoren der Signaltransduktionswege
AU2006313701B2 (en) * 2005-11-11 2012-05-31 Aeterna Zentaris Gmbh Novel pyridopyrazines and their use as modulators of kinases
EP1956910B1 (de) * 2005-11-23 2014-09-17 The Board of Regents of The University of Texas System Für onkogenes ras spezifische cytotoxische verbindung und verfahren zu ihrer verwendung
CA2660704A1 (en) * 2006-08-07 2008-02-14 Ironwood Pharmaceuticals, Inc. Indole compounds
EP2091532A1 (de) * 2006-11-28 2009-08-26 Ziopharm Oncology, Inc. Verwendung von indolyl-3-glyoxylsäure-derivaten einschliesslich indibulin, allein oder in kombination mit weiteren mitteln zur behandlung von krebs
RU2519145C2 (ru) * 2008-10-16 2014-06-10 Эррэй Биофарма Инк. Ингибиторы митоза для интенсификации процесса апоптоза при терапии
WO2012017325A2 (en) * 2010-07-19 2012-02-09 Procaps Sa Apparatus and process for encapsulating microparticles with liquid in soft gel capsules

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6232327B1 (en) * 1998-04-02 2001-05-15 Asta Medica Aktiengesellschaft Indolyl-3-glyoxylic acid derivatives having antitumor action
WO2002008225A1 (en) * 2000-07-25 2002-01-31 Novuspharma S.P.A. 2-(1h-indol-3-yl)-2-oxo-acetic acid amides with antitumor activity
WO2003022280A2 (en) * 2001-09-13 2003-03-20 Synta Pharmaceuticals Corp. 3-glyoxlylamideindoles for treating cancer
US20030100597A1 (en) * 2000-07-28 2003-05-29 Peter Emig Novel indole derivatives and their use as medicaments

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI269654B (en) * 1999-09-28 2007-01-01 Baxter Healthcare Sa N-substituted indole-3-glyoxylamide compounds having anti-tumor action
DE19962300A1 (de) * 1999-12-23 2001-06-28 Asta Medica Ag Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6232327B1 (en) * 1998-04-02 2001-05-15 Asta Medica Aktiengesellschaft Indolyl-3-glyoxylic acid derivatives having antitumor action
WO2002008225A1 (en) * 2000-07-25 2002-01-31 Novuspharma S.P.A. 2-(1h-indol-3-yl)-2-oxo-acetic acid amides with antitumor activity
US20030100597A1 (en) * 2000-07-28 2003-05-29 Peter Emig Novel indole derivatives and their use as medicaments
WO2003022280A2 (en) * 2001-09-13 2003-03-20 Synta Pharmaceuticals Corp. 3-glyoxlylamideindoles for treating cancer

Also Published As

Publication number Publication date
RU2006100022A (ru) 2006-05-27
KR20060034230A (ko) 2006-04-21
EP1641777A1 (de) 2006-04-05
JP2007523850A (ja) 2007-08-23
CA2526663C (en) 2011-07-19
NZ543853A (en) 2009-09-25
RS20050901A (en) 2007-12-31
AU2004245198A1 (en) 2004-12-16
CN1816543A (zh) 2006-08-09
MXPA05013121A (es) 2006-03-17
CA2526663A1 (en) 2004-12-16
BRPI0410998A (pt) 2006-07-04
WO2004108702A1 (de) 2004-12-16
KR101132599B1 (ko) 2012-06-21
JP4878285B2 (ja) 2012-02-15
CN1816543B (zh) 2011-01-19
RU2327696C2 (ru) 2008-06-27

Similar Documents

Publication Publication Date Title
KR102520543B1 (ko) 피리딘 화합물
CA2586271C (en) Anthranilamide pyridinureas as vascular endothelial growth factor (vegf)receptor kinase inhibitors
JP6582056B2 (ja) Ｃｘｃｒ７受容体調節剤
CA2999379A1 (en) 2-oxo-1,2-dihydropyridine-3,5-dicarboxamide compounds as bromodomain inhibitors
KR20170082632A (ko) 소마토스타틴 수용체 아형 4 (sstr4) 작용제로서의 모르폴린 및 1,4-옥사제판 아미드
US7205299B2 (en) Indole derivatives having an apoptosis-inducing effect
AU2004245198B2 (en) Indole derivatives with apoptosis-inducing effect
CN109790156B (zh) 具有刺猬通路拮抗剂活性的手性杂环化合物及其制备方法和应用
EP3966208A2 (de) Verbindungen und verfahren zur behandlung von krebs
CN116870016B (zh) 杂芳环化合物及其医药用途
EP1655297A1 (de) Nicotinamidpyridinharnstoffe als Kinaseinhibitoren des Rezeptors des vaskulären endothelialen Wachstumsfaktors (VEGF)
CN111875583B (zh) 三氮唑衍生物及其制备方法和用途
CN113912563A (zh) 一种苯并五元氮杂环化合物及其应用
ZA200509475B (en) Indole derivatives with apoptosis-inducing effect
CN117777132A (zh) α-N-芳基氨基酰胺及其制备方法和药用用途
EP1595878A1 (de) Indolderivate mit Apoptose induzierender Wirkung

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired